When Silence is Golden in MedTech Reimbursement

Published on: 30/10/2024

In MedTech reimbursement, no news can be good news. Learn how to reduce payer confusion and build clarity into your strategy.

Payer CoverageCommercialization
When Silence is Golden in MedTech Reimbursement

The World After FDA Clearance: From HOORAY! To WAIT, WHAT?

Published on: 20/08/2024

FDA clearance is a milestone—not the finish line. Why reimbursement hurdles follow right after.

CommercializationFundamentalsFeatured
The World After FDA Clearance: From HOORAY! To WAIT, WHAT?

Relearning English When it Comes to FDA and CMS Jargon

Published on: 04/06/2024

MedTech teams often misunderstand what regulators mean. This article translates FDA and CMS jargon into actionable insights for reimbursement.

FundamentalsFeatured
Relearning English When it Comes to FDA and CMS Jargon

What Do Payers Mean by “Clinical Utility”?

Published on: 01/06/2024

“Clinical utility” is one of the most misunderstood payer terms. This article explains what U.S. payers expect and how to prepare.

Payer CoverageEvidence Planning
What Do Payers Mean by “Clinical Utility”?